These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7754791)

  • 21. New antiretrovirals and new combinations.
    Havlir DV; Lange JM
    AIDS; 1998; 12 Suppl A():S165-74. PubMed ID: 9632999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Challenges for the clinical development of new nucleoside reverse transcriptase inhibitors for HIV infection.
    Wainberg MA; Sawyer JP; Montaner JS; Murphy RL; Kuritzkes DR; Raffi F
    Antivir Ther; 2005; 10(1):13-28. PubMed ID: 15751760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
    Pinheiro Edos S; Antunes OA; Fortunak JM
    Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Practical issues regarding the use of antiretroviral therapy for HIV infection.
    Deeks SG
    West J Med; 1998 Feb; 168(2):133-9. PubMed ID: 9499754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nucleoside analogue-sparing strategy for the treatment of chronic HIV infection: potential interest and clinical experience.
    Joly V; Yeni P
    Antivir Ther; 2005; 10(1):29-40. PubMed ID: 15751761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [More drugs against HIV/AIDS will soon be available as a review over the drug development shows].
    Oberg B
    Lakartidningen; 1991 Nov; 88(48):4139-42. PubMed ID: 1956253
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antiretroviral treatments and their therapeutical trials].
    Bazin C; Régnier B
    Rev Prat; 1992 Jan; 42(2):148-53. PubMed ID: 1565997
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic aspects of retroviral disease.
    Peto T
    Baillieres Clin Neurol; 1992 Apr; 1(1):239-57. PubMed ID: 1344652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiretroviral agents in the nineties.
    Sutherland DC
    Med J Aust; 1992 Jul; 157(2):135-8. PubMed ID: 1630378
    [No Abstract]   [Full Text] [Related]  

  • 30. Toward improved anti-HIV chemotherapy: therapeutic strategies for intervention with HIV infections.
    De Clercq E
    J Med Chem; 1995 Jul; 38(14):2491-517. PubMed ID: 7543152
    [No Abstract]   [Full Text] [Related]  

  • 31. Summary of track A: basic science.
    Birx DL; VanCott T; Michael N; McNeil J; Stamatos N; Gilliam B; Davis R; Carr J; McCutchan F
    AIDS; 1996 Dec; 10 Suppl 3():S85-106. PubMed ID: 8970716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnosis and early treatment of HIV infection].
    Goebel FD
    Immun Infekt; 1993 Aug; 21(4):104-5. PubMed ID: 8370591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-HIV activity of cosalane.
    Choo V
    Lancet; 1993 Sep; 342(8873):733. PubMed ID: 8103830
    [No Abstract]   [Full Text] [Related]  

  • 34. Mutation rate and the efficacy of antimicrobial drug treatment.
    Gerrish PJ; García-Lerma JG
    Lancet Infect Dis; 2003 Jan; 3(1):28-32. PubMed ID: 12505030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cytokine network in HIV infection.
    Alfano M; Poli G
    Curr Mol Med; 2002 Dec; 2(8):677-89. PubMed ID: 12462389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conference summary: novel HIV therapies--from discovery to clinical proof of concept.
    Miller RH; Turk SR; Black RJ; Bridges S; Sarver N
    AIDS Res Hum Retroviruses; 1996 Jul; 12(10):859-65. PubMed ID: 8798970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiretroviral treatments in 2012: improvements and future prospects.
    Charpentier C; Joly V; Yeni P; Brun-Vézinet F
    Virologie (Montrouge); 2013 Jun; 17(3):182-192. PubMed ID: 31910545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on antiretroviral therapy of HIV infection.
    Vella S
    J Biol Regul Homeost Agents; 1994; 8(3):71-6. PubMed ID: 7754791
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.